Persistent nasal methicillin-resistant staphylococcus aureus carriage in hemodialysis outpatients: A predictor of worse outcome

BMC Nephrology

Volumn 14, Issue 1, 2013, Pages

  Schmid, Holger ^a,b   Romanos, Andre ^a   Schiffl, Helmut ^a,b   Lederer, Stephan R ^a,b  

^a Nierenzentrum Muenchen Laim   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Comorbidity; ESRD; Hemodialysis; MRSA; Outcome; Staphylococcus aureus

Indexed keywords

CHLORHEXIDINE; OCTENIDINE; PSEUDOMONIC ACID;

ADULT; ARTICLE; ASEPSIS; BACTERIAL COLONIZATION; BACTERIUM CULTURE; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEMODIALYSIS; HUMAN; INFECTION PREVENTION; INFECTION RISK; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; MEDICAL HISTORY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NONHUMAN; NOSE SMEAR; OUTPATIENT; PREDICTION; PROSPECTIVE STUDY; TREATMENT OUTCOME;

AGED; AMBULATORY CARE; CARRIER STATE; COHORT STUDIES; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; NASAL MUCOSA; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RENAL DIALYSIS; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS; TREATMENT OUTCOME;

EID: 84876724307     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-14-93     Document Type: Article

References (39)

1. Hemodialysis. Himmelfarb J, Ikizler TA, N Engl J Med 2010 363 19 1833 1845 10.1056/NEJMra0902710 21047227
2. Staphylococcus aureus infections in hemodialysis: what a nephrologist should know. Vandecasteele SJ, Boelaert JR, De Vriese AS, Clin J Am Soc Nephrol 2009 4 8 1388 1400 10.2215/CJN.01590309 19590063
3. Prevalence of colonization with community-associated methicillin- resistant Staphylococcus aureus among end-stage renal disease patients and healthcare workers. Johnson LB, Jose J, Yousif F, Pawlak J, Saravolatz LD, Infect Control Hosp Epidemiol 2009 30 1 4 8 10.1086/592983 19046060
4. Mortality risk factors in chronic haemodialysis patients with infective endocarditis. Nori US, Manoharan A, Thornby JI, Yee J, Parasuraman R, Ramanathan V, Nephrol Dial Transplant 2006 21 8 2184 2190 10.1093/ndt/gfl200 16644778 (Pubitemid 44295044)
5. Management of gram-positive coccal bacteremia and hemodialysis. Fitzgibbons LN, Puls DL, Mackay K, Forrest GN, Am J Kidney Dis 2011 57 4 624 640 10.1053/j.ajkd.2010.12.013 21333430
6. Patients at risk of complications of Staphylococcus aureus bloodstream infection. del Rio A, Cervera C, Moreno A, Moreillon P, Miró JM, Clin Infect Dis 2009 48 Suppl 4 246 S253 19374580
7. The challenge of methicillin-resistant Staphylococcus aureus prevention in hemodialysis therapy. Parker MG, Doebbeling BN, Semin Dial 2012 25 1 42 49 10.1111/j.1525-139X.2011.00999.x 22150691
8. Nasal carriage of methicillin-resistant Staphylococcus aureus is associated with higher all-cause mortality in hemodialysis patients. Lai CF, Liao CH, Pai MF, Chu FY, Hsu SP, Chen HY, Yang JY, Chiu YL, Peng YS, Chang SC, Hung KY, Tsai TJ, Wu KD, Clin J Am Soc Nephrol 2011 6 1 167 174 10.2215/CJN.06270710 20947786
9. Methicillin-resistant Staphylococcus aureus infection in the Texas prison system. Baillargeon J, Kelley MF, Leach CT, Baillargeon G, Pollock BH, Clin Infect Dis 2004 38 9 92 e95 10.1086/383146 15127360
10. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. Charlson ME, Pompei P, Ales KL, MacKenzie CR, J Chronic Dis 1987 40 5 373 383 10.1016/0021-9681(87)90171-8 3558716 (Pubitemid 17055592)
11. The epidemiology, treatment, and prevention of transmission of methicillin-resistant Staphylococcus aureus. Calfee DP, J Infus Nurs 2011 34 6 359 364 10.1097/NAN.0b013e31823061d6 22101629
12. Nasal carriage of meticillin resistant Staphylococcus aureus: the prevalence, patients at risk and the effect of elimination on outcomes among outclinic haemodialysis patients. Lederer SR, Riedelsdorf G, Schiffl H, Eur J Med Res 2007 12 7 284 288 17933699 (Pubitemid 47207728)
13. Highly effective regimen for decolonization of methicillin-resistant Staphylococcus aureus carriers. Buehlmann M, Frei R, Fenner L, Dangel M, Fluckiger U, Widmer AF, Infect Control Hosp Epidemiol 2008 29 6 510 516 10.1086/588201 18510460 (Pubitemid 351918029)
14. Use of octenidine dihydrochloride in meticillin-resistant Staphylococcus aureus decolonisation regimens: a literature review. Krishna BV, Gibb AP, J Hosp Infect 2010 74 3 199 203 10.1016/j.jhin.2009.08.022 20060619
15. UK Renal Registry 12th Annual Report (December 2009): chapter 12: epidemiology of methicillin resistant Staphylococcus aureus bacteraemia amongst patients receiving dialysis for established renal failure in England in 2008: a joint report from the UK Renal Registry and the Health Protection Agency. Fluck R, Wilson J, Tomson CR, Nephron Clin Pract 2010 115 Suppl 1 261 c270 20413950
16. MRSA prevalence in European healthcare settings: a review. Dulon M, Haamann F, Peters C, Schablon A, Nienhaus A, BMC Infect Dis 2011 11 138 10.1186/1471-2334-11-138 21599908
17. Prevalence and risk factors for methicillin-resistant Staphylococcus aureus colonization among outpatients undergoing hemodialysis treatment. Köseoǧlu O, Sayin Kutlu S, Cevahir N, Mikrobiyol Bul 2012 46 1 106 112 22399178
18. Clinical and molecular epidemiology of methicillin-resistant Staphylococcus aureus among patients in an ambulatory hemodialysis center. Patel G, Jenkins SG, Mediavilla JR, Kreiswirth BN, Radbill B, Salgado CD, Calfee DP, Infect Control Hosp Epidemiol 2011 32 9 881 888 10.1086/661598 21828968
19. The prevalence of resistant bacterial colonization in chronic hemodialysis patients. Hadley AC, Karchmer TB, Russell GB, McBride DG, Freedman BI, Am J Nephrol 2007 27 4 352 359 10.1159/000103383 17541264 (Pubitemid 47077199)
20. Risk factors for nasal carriage of methicillin-resistant Staphylococcus aureus among patients with end-stage renal disease in Taiwan. Wang CY, Wu VC, Wang WJ, Lin YF, Lin YH, Chen YM, Su CT, Wang JY, Wu KD, Hsueh PR, J Formos Med Assoc 2012 111 1 14 18 10.1016/j.jfma.2012.01.001 22333007
21. Prevalence of nasal Staphylococcus aureus carriage in the patients undergoing hemodialysis and evaluation of risk factors and laboratory parameters. Celik G, Gülcan A, Dikici N, Gülcan E, Ren Fail 2011 33 5 494 498 10.3109/0886022X.2011.573896 21545312
22. European society of clinical microbiology and infectious diseases (ESCMID); international society of chemotherapy (ISC). meticillin-resistant staphylococcus aureus (MRSA): screening and decolonisation. Cookson B, Bonten MJ, Mackenzie FM, Skov RL, Verbrugh HA, Tacconelli E, Int J Antimicrob Agents 2011 37 3 195 201 10.1016/j.ijantimicag.2010.10.023 21163631
23. Staphylococcal decolonisation: an effective strategy for prevention of infection? Simor AE, Lancet Infect Dis 2011 11 12 952 962 10.1016/S1473-3099(11) 70281-X 22115070
24. Decolonization therapy in infection control. Hebert C, Robicsek A, Curr Opin Infect Dis 2010 23 4 340 345 10.1097/QCO.0b013e32833ae214 20485164
25. Quantifying the impact of extranasal testing of body sites for methicillin-resistant Staphylococcus aureus colonization at the time of hospital or intensive care unit admission. McKinnell JA, Huang SS, Eells SJ, Cui E, Miller LG, Infect Control Hosp Epidemiol 2013 34 2 161 170 10.1086/669095 23295562
26. Staphylococcus aureus bloodstream infections: risk factors, outcomes, and the influence of methicillin resistance in Calgary, Canada, 2000-2006. Laupland KB, Ross T, Gregson DB, J Infect Dis 2008 198 3 336 343 10.1086/589717 18522502
27. Impact of USA300 methicillin-resistant Staphylococcus aureus on clinical outcomes of patients with pneumonia or central line-associated bloodstream infections. Lessa FC, Mu Y, Ray SM, Dumyati G, Bulens S, Gorwitz RJ, Fosheim G, DeVries AS, Schaffner W, Nadle J, Gershman K, Fridkin SK, Active Bacterial Core surveillance (ABCs), Clin Infect Dis 2012 55 2 232 241 10.1093/cid/cis408 22523264
28. Staphylococcus aureus bacteremia in older adults: predictors of 7-day mortality and infection with a methicillin-resistant strain. Bader MS, Infect Control Hosp Epidemiol 2006 27 11 1219 1225 10.1086/507924 17080380 (Pubitemid 44807466)
29. Prevalence and risk factors of methicillin-resistant Staphylococcus aureus colonization among residents living in long-term care facilities in southern Spain. García-García JA, Santos-Morano J, Castro C, Bayoll-Serradilla E, Martín-Ponce ML, Vergara-López S, Martín-Rodríguez LM, Mateos-Gómez A, de la Cueva J, Martín-Mazuelos E, Gómez-Mateos JM, Corzo-Delgado JE, Enferm Infecc Microbiol Clin 2011 29 6 405 410 10.1016/j.eimc.2010.12.010 21349606
30. Invasive methicillin-resistant Staphylococcus aureus infections among dialysis patients - United States, 2005. Centers for Disease Control and Prevention (CDC), MMWR Morb Mortal Wkly Rep 2007 56 9 197 199 17347644
31. Active surveillance to determine the impact of methicillin-resistant Staphylococcus aureus colonization on patients in intensive care units of a Veterans Affairs Medical Center. Patel M, Weinheimer JD, Waites KB, Baddley JW, Infect Control Hosp Epidemiol 2008 29 6 503 509 10.1086/588161 18510459 (Pubitemid 351918028)
32. Diagnostic accuracy of culture-based and PCR-based detection tests for methicillin-resistant Staphylococcus aureus: a meta-analysis. Luteijn JM, Hubben GA, Pechlivanoglou P, Bonten MJ, Postma MJ, Clin Microbiol Infect 2011 17 2 146 154 10.1111/j.1469-0691.2010.03202.x 20219085
33. Emergence of community-associated methicillin-resistant Staphylococcus aureus infection among patients with end-stage renal disease. Johnson LB, Venugopal AA, Pawlak J, Saravolatz LD, Infect Control Hosp Epidemiol 2006 10 1057 1062 (Pubitemid 44670981)
34. Comparison between patients under hemodialysis with community-onset bacteremia caused by community-associated and healthcare-associated methicillin-resistant Staphylococcus aureus strains. Wu HS, Kuo SC, Chen LY, Chiang MC, Lin YT, Wang FD, Fung CP, J Microbiol Immunol Infect 2012 46 2 96 103 22520272
35. Prospective genotyping of hospital-acquired methicillin-resistant Staphylococcus aureus isolates by use of a novel, highly discriminatory binary typing system. O'Sullivan MV, Zhou F, Sintchenko V, Gilbert GL, J Clin Microbiol 2012 50 11 3513 9 10.1128/JCM.01625-12 22895043
36. Mupirocin resistance. Patel JB, Gorwitz RJ, Jernigan JA, Clin Infect Dis 2009 49 6 935 41 10.1086/605495 19673644
37. Low adherence to outpatient preoperative methicillin-resistant Staphylococcus aureus decolonization therapy. Caffrey AR, Woodmansee SB, Crandall N, Tibert C, Fielding C, Mikolich DJ, Vezeridis MP, LaPlante KL, Infect Control Hosp Epidemiol 2011 32 9 930 2 10.1086/661787 21828980
38. Utility of the chronic disease score and Charlson Comorbidity index as comorbidity measures for use in epidemiologic studies of antibiotic-resistant organisms. McGregor JC, Kim PW, Perencevich EN, Bradham DD, Furuno JP, Kaye KS, Fink JC, Langenberg P, Roghmann MC, Harris AD, Am J Epidemiol 2005 161 5 483 93 10.1093/aje/kwi068 15718484 (Pubitemid 40315619)
39. Risk of cardiovascular events after infection-related hospitalizations in older patients on dialysis. Dalrymple LS, Mohammed SM, Mu Y, Johansen KL, Chertow GM, Grimes B, Kaysen GA, Nguyen DV, Clin J Am Soc Nephrol 2011 6 7 1708 13 10.2215/CJN.10151110 21566109